1. Fluorescent Quantum Dots (QDs): A Theranostic Tool for Breast Cancer Management
    Joga Singh et al, 2022, Biomedical Translational Research CrossRef
  2. Aptamer-Conjugated Calcium Phosphate Nanoparticles for Reducing Diabetes Risk via Retinol Binding Protein 4 Inhibition
    Raheleh Torabi et al, 2017, Canadian Journal of Diabetes CrossRef
  3. Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative
    Maria Scuotto et al, 2015, Nucleic Acids Research CrossRef
  4. Plasminogen Activator Inhibitor-1
    Deniz Agirbasli et al, 2018, Encyclopedia of Signaling Molecules CrossRef
  5. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances
    Mohsen Ghaferi et al, 2021, Journal of Drug Targeting CrossRef
  6. Investigation of the complex structure, comparative DNA-binding and DNA cleavage of two water-soluble mono-nuclear lanthanum(III) complexes and cytotoxic activity of chitosan-coated magnetic nanoparticles as drug delivery for the complexes
    Zahra Asadi et al, 2017, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
  7. AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics
    Pardis Mohammadzadeh et al, 2017, Scientific Reports CrossRef
  8. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
    Xiaodong Xie et al, 2016, European Journal of Pharmaceutical Sciences CrossRef
  9. Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
    Farhoodeh Ghaedrahmati et al, 2023, Cancer Communications CrossRef
  10. Essential strategies to optimize asymmetric PCR conditions as a reliable method to generate large amount of ssDNA aptamers
    Mohammad Heiat et al, 2017, Biotechnology and Applied Biochemistry CrossRef
  11. In situfluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase
    Haibin Si et al, 2018, Chemical Communications CrossRef
  12. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma
    Mateja Delač et al, 2015, Cytometry Part A CrossRef
  13. Nucleic Acid Aptamer‐Mediated Drug Delivery for Targeted Cancer Therapy
    Huijie Zhu et al, 2015, ChemMedChem CrossRef
  14. A dual-signal mode electrochemical aptasensor based on tetrahedral DNA nanostructures for sensitive detection of citrinin in food using PtPdCo mesoporous nanozymes
    Shi Tang et al, 2024, Food Chemistry CrossRef
  15. Novel β-lactam antibiotic derivative and its complexes: DFT, frontier energy levels, DNA interaction, docking, physicochemical and antimicrobial properties
    Abbas M. Abbas et al, 2020, Journal of Molecular Structure CrossRef
  16. FRET-Based Aptasensor for the Selective and Sensitive Detection of Lysozyme
    Kumar Sapkota et al, 2020, Sensors CrossRef
  17. Recent advances in aptamer-based sensors for breast cancer diagnosis: special cases for nanomaterial-based VEGF, HER2, and MUC1 aptasensors
    Samet Şahin et al, 2020, Microchimica Acta CrossRef
  18. Aptamers as radiopharmaceuticals for nuclear imaging and therapy
    Marlies Gijs et al, 2016, Nuclear Medicine and Biology CrossRef
  19. Modern affinity reagents: Recombinant antibodies and aptamers
    Katherine Groff et al, 2015, Biotechnology Advances CrossRef
  20. Current approaches in SELEX: An update to aptamer selection technology
    Mariia Darmostuk et al, 2015, Biotechnology Advances CrossRef
  21. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro
    Bindong Dai et al, 2016, Oncotarget CrossRef
  22. Targeted and stimuli–responsive mesoporous silica nanoparticles for drug delivery and theranostic use
    Md Aquib et al, 2019, Journal of Biomedical Materials Research Part A CrossRef
  23. A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer
    Nilesh Malavia et al, 2021, Journal of Controlled Release CrossRef
  24. Advances of aptamer-based small-molecules sensors in body fluids detection
    Li Chen et al, 2024, Talanta CrossRef
  25. Aptamer and its applications in neurodegenerative diseases
    Jing Qu et al, 2017, Cellular and Molecular Life Sciences CrossRef
  26. Aptamers for the Diagnosis and Therapy of Neurodegenerative Diseases
    Jing Qu et al, 2021, Aptamers for Medical Applications CrossRef
  27. DNA aptamer-based affinity chromatography system for purification of recombinant proteins tagged with lysine tag
    Klaudia Arciszewska et al, 2023, Journal of Chromatography A CrossRef

  28. Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma


    Kai-Cai Liu et al, 2020, Drug Design, Development and Therapy CrossRef
  29. Biotechnologie und Bioverfahrenstechnik – Vom ersten Ullmanns Artikel bis hin zu aktuellen Forschungsthemen
    Huschyar Al‐Kaidy et al, 2014, Chemie Ingenieur Technik CrossRef
  30. Trends in aptamer selection methods and applications
    Meral Yüce et al, 2015, The Analyst CrossRef
  31. Aptamers in analytics
    Muslum Ilgu et al, 2016, The Analyst CrossRef
  32. Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
    Long Li et al, 2021, Angewandte Chemie International Edition CrossRef
  33. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer
    Seyed Hossein Rajabnejad et al, 2018, Drug Development and Industrial Pharmacy CrossRef
  34. Stimuli-sensitive Chitosan-based Nanosystems-immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma
    Seyed Morteza Naghib et al, 2024, Current Topics in Medicinal Chemistry CrossRef
  35. Biomedical applications of aptamer-modified chitosan nanomaterials: An updated review
    Sonia Fathi-Karkan et al, 2023, International Journal of Biological Macromolecules CrossRef
  36. Metal complex interactions with DNA
    Benjamin J. Pages et al, 2015, Dalton Transactions CrossRef
  37. Mesoporous Silica Nanoparticles for Targeted and Stimuli‐Responsive Delivery of Chemotherapeutics: A Review
    Antti Rahikkala et al, 2018, Advanced Biosystems CrossRef
  38. Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics
    Marina A Dobrovolskaia et al, 2015, Expert Opinion on Biological Therapy CrossRef
  39. Aptamer-Based Probes for Cancer Diagnostics and Treatment
    Xueqi Hu et al, 2022, Life CrossRef
  40. Aptamer Validation by Western Blot–an overview
    null Lamees Jamal Talib et al, 2022, Al Mustansiriyah Journal of Pharmaceutical Sciences CrossRef
  41. Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
    Long Li et al, 2021, Angewandte Chemie CrossRef
  42. 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery
    Lei Kang et al, 2019, RNA Interference and Cancer Therapy CrossRef
  43. Aptamers: A promising chemical antibody for cancer therapy
    Gang Zhou et al, 2016, Oncotarget CrossRef
  44. Analysis of ATP and AMP binding to a DNA aptamer and its imidazole-tethered derivatives by surface plasmon resonance
    Jing Zhao et al, 2015, The Analyst CrossRef
  45. Plasminogen Activator Inhibitor-1
    Deniz Agirbasli et al, 2017, Encyclopedia of Signaling Molecules CrossRef
  46. A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
    Gary A. Clawson et al, 2017, Nucleic Acid Therapeutics CrossRef
  47. Biotechnology and Bioprocess Engineering – From the First Ullmann's Article to Recent Trends
    Huschyar Al‐Kaidy et al, 2015, ChemBioEng Reviews CrossRef
  48. Recent Advances in the Selection of Cancer-Specific Aptamers for the Development of Biosensors
    Diana A. Sousa et al, 2022, Current Medicinal Chemistry CrossRef
  49. DNA aptamer affinity ligands for highly selective purification of human plasma-related proteins from multiple sources
    Cynthia Forier et al, 2017, Journal of Chromatography A CrossRef
  50. Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles
    Santosh Sarnaik et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
  51. Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
    Gail L. Matters et al, 2018, Biomedicines CrossRef
  52. Aptamer-functionalized quantum dots for targeted cancer therapy
    Fatemeh Yazdian, 2023, Aptamers Engineered Nanocarriers for Cancer Therapy CrossRef
  53. Screening the efficient biological prospects of triazole allied mixed ligand metal complexes
    Ponnukalai Ponya Utthra et al, 2017, Journal of Molecular Structure CrossRef
  54. Antiproliferative Effects of the Aptamer d(GGGT)4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells
    Antonella Virgilio et al, 2022, International Journal of Molecular Sciences CrossRef
  55. An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
    Kyun Heo et al, 2016, Journal of Controlled Release CrossRef
  56. DNA binding and Topoisomerase inhibition: How can these mechanisms be explored to design more specific anticancer agents?
    Sinara Mônica Vitalino de Almeida et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  57. AS1411 aptamer improves therapeutic efficacy of PEGylated nanoliposomes loaded with gefitinib in the mice bearing CT26 colon carcinoma
    Hamid Tanzadehpanah et al, 2022, Journal of Nanoparticle Research CrossRef
  58. DNA Binding, amelioration of oxidative stress, and molecular docking study of Zn(II) metal complex of a new Schiff base ligand
    Dipu Kumar Mishra et al, 2018, Journal of Coordination Chemistry CrossRef